Observational cohort study of rilpivirine (RPV) utilization in Europe

Autor: Alessandro Cozzi-Lepri, Lars Peters, Annegret Pelchen-Matthews, Bastian Neesgaard, Stephane De Wit, Isik Somuncu Johansen, Simon Edwards, Christoph Stephan, Georgios Adamis, Therese Staub, Alexandra Zagalo, Pere Domingo, Daniel Elbirt, Katharina Kusejko, Johanna Brännström, Dzmitry Paduta, Tatyana Trofimova, Janos Szlavik, Kai Zilmer, Marcello Losso, Veerle Van Eygen, Helen Pai, Jens Lundgren, Amanda Mocroft, for the EuroSIDA Study Group

Publikováno v: AIDS Research and Therapy, Vol 19, Iss 1, Pp 1-12 (2022)

Abstract Introduction Data on safety and effectiveness of RPV from the real-world setting as well as comparisons with other NNRTIs such as efavirenz (EFV) remain scarce. Methods Participants of EuroSIDA were included if they had started a RPV- or an

Externí odkaz: https://doaj.org/article/52e7fe1dd5e244669b712b449eee7437

Incidence and risk factors for suicide, death due to substance use, and violent/accidental death in people with HIV

Autor: Erich S. Tusch, Lene Ryom, Olga Fursa, Lars Peters, Lars Østergaard, Eric Florence, Simon Edwards, Christian Hoffmann, Helen Sambatakou, Peter Reiss, Eduardo Shahar, Dag Henrik Reikvam, Brigitte Schmied, Dzmitry Paduta, Alexei Yakovlev, János Szlávik, Jovan Ranin, Kai Zilmer, Vilma Uždaviniene, Annegret Pelchen-Matthews, Amanda Mocroft, Joanne Reekie

Publikováno v: Tusch, E S, Ryom, L, Fursa, O, Peters, L, Østergaard, L, Florence, E, Edwards, S, Hoffmann, C, Sambatakou, H, Reiss, P, Shahar, E, Reikvam, D H, Schmied, B, Paduta, D, Yakovlev, A, Szlávik, J, Ranin, J, Zilmer, K, Uždaviniene, V, Pelchen-Matthews, A, Mocroft, A & Reekie, J 2023, ' Incidence and risk factors for suicide, death due to substance use, and violent/accidental death in people with HIV ', AIDS, vol. 37, no. 1, pp. 161-171 . https://doi.org/10.1097/QAD.0000000000003402

OBJECTIVE: Deaths due to suicide, substance use and violence/accident may reflect similar risk factors and overlap in their classification. This study aimed to investigate incidence and risk factors of mortality among people with HIV (PWH) due to the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::244c8c830db579cf9ca286d0e0fa438b
https://doi.org/10.1097/qad.0000000000003402

Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or Death.

Autor: Maria Casadellà, Alessandro Cozzi-Lepri, Andrew Phillips, Marc Noguera-Julian, Markus Bickel, Dalibor Sedlacek, Kai Zilmer, Bonaventura Clotet, Jens D Lundgren, Roger Paredes, EuroSIDA in EuroCOORD

Publikováno v: PLoS ONE, Vol 12, Iss 1, p e0166613 (2017)

OBJECTIVETo investigate if plasma HIV-1 tropism testing could identify subjects at higher risk for clinical progression and death in routine clinical management.DESIGNNested case-control study within the EuroSIDA cohort.METHODSCases were subjects wit

Externí odkaz: https://doaj.org/article/1c762a07324c46afa09a1e21d4306f35

Dynamics of hepatitis C epidemic among people living with HIV in Estonia

Autor: Radko Avi, Karolin Toompere, Pilleriin Soodla, Kristi Huik, Ene-Ly Jõgeda, Heli Rajasaar, Irja Lutsar, Kai Zilmer, Kerstin Kase, Merit Pauskar

Background Estonia has a typical Eastern European HIV epidemic where the most frequent co-infection is chronic hepatitis C (HCV). We aimed to describe the changes in HCV prevalence, the distribution of HCV genotypes (GT), and HCV treatment in Estonia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9a85709201bb7077bc418766a4521142
https://doi.org/10.21203/rs.3.rs-17310/v1

Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals

Autor: Karine Lacombe, Juergen K. Rockstroh, Del Campo S, Robert Zangerle, Gatell Jm, Lars Peters, Pere Domingo, Tatyana Trofimova, Andri Rauch, Jens D Lundgren, Nikoloz Chkhartishvili, Karolin Falconer, Raimonda Matulionyte, Mitsura, Dzmitry Paduta, Chiara Resnati, Thomas Benfield, Irina Khromova, Amanda Mocroft, Clifford Leen, Kamilla Laut, Kai Zilmer

Publikováno v: AIDS
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Universitat Pompeu Fabra
Peters, L, Laut, K, Resnati, C, Del Campo, S, Leen, C, Falconer, K, Trofimova, T, Paduta, D, Gatell, J, Rauch, A, Lacombe, K, Domingo, P, Chkhartishvili, N, Zangerle, R, Matulionyte, R, Mitsura, V, Benfield, T, Zilmer, K, Khromova, I, Lundgren, J, Rockstroh, J, Mocroft, A & EuroSIDA Study Group 2018, ' Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals ', AIDS, vol. 32, no. 14, pp. 1995-2004 . https://doi.org/10.1097/QAD.0000000000001928

Background and aims: To investigate the uptake of hepatitisCvirus (HCV) therapy among HIV/HCV-coinfectedpatients inthepan-EuropeanEuroSIDAstudybetween2011and2016. Methods: All HCV-RNA patients were included. Baseline was defined as latest of anti-HCV

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ae1324679d7524216cc3eb1223e53bd
https://pubmed.ncbi.nlm.nih.gov/29912062